ASAP Blog

Looking to engage with our member community by contributing to ASAP’s content? Send your blog post, article draft, or idea to Michael Burke at mburke@strategic-alliances.org

Alliance Excellence Award ASAP Publications ASAP Short Takes ASAP Webinar BioPharma Conference Community Partnership Contributed Content European Alliance Summit Global Alliance Summit Job Board Member Resources Program Executive Summary Program Executive Summary : ASAP Roundtables Program Executive Summary : Collaborative Connections Program Executive Summary : Virtual Programs

Join Our Shared Alliance Aces Community Today!
Join Our Shared Alliance Aces Community Today!

ASAP Members are now able to join our shared online community for alliance and ecosystem professionals -- the Alliance Aces Community! ASAP members now have access to additional best practices, ecosystem-related discussions, job posts, upcoming events, fresh new videos, ASAP Certification... Continue Reading

Postedby Kimberly Miller
Date posted10/16/2019


ASAP and WorkSpan Announce a Partnership to Strengthen Their Collaboration and Grow the Ecosystem Co
ASAP and WorkSpan Announce a Partnership to Strengthen Their Collaboration and Grow the Ecosystem Co

Updated: Monday, September 30, 2019 WorkSpan and the Association of Strategic Alliance Professionals (ASAP), two organizations that are deeply engaged with alliance and ecosystem professionals, are proud to announce a new partnership designed to grow and enhance both organizations’... Continue Reading

Postedby Kimberly Miller
Date posted09/30/2019


Where Hope IS the Strategy: Customizing Alliance Management to Fight Deadly Disease
Where Hope IS the Strategy: Customizing Alliance Management to Fight Deadly Disease

Updated: Friday, September 27, 2019 Andre Turenne began his Wednesday keynote address at the 2019 ASAP BioPharma Conference , held Sept. 23­–25 in Boston, by reminding everyone why biopharma companies form partnerships in the first place: to more effectively find and create new... Continue Reading

Postedby Michael Burke
Date posted09/30/2019


Your Move: Changing Jobs in Biopharma Alliance Management
Your Move: Changing Jobs in Biopharma Alliance Management

Updated: Friday, September 27, 2019 A perennial topic of interest in the ASAP biopharma community—and alliance management in general—revolves around plotting one’s career path and changing jobs, whether that means moving to a new company or shifting to a new job in one’s... Continue Reading

Postedby Michael Burke
Date posted09/27/2019


An Inside Job: Building Alliance Management Culture
An Inside Job: Building Alliance Management Culture

“We see at the highest levels of business and government what happens when we don’t maintain and preserve alliances.” Such was the plain, blunt statement of Rob Bazemore, president and CEO of Epizyme, Inc., Tuesday’s keynote speaker at the 2019 ASAP BioPharma Conference,... Continue Reading

Postedby Michael Burke
Date posted09/27/2019


Where’s the Love? Alliance Managers Show Some…to Medical Affairs
Where’s the Love? Alliance Managers Show Some…to Medical Affairs

Perhaps one of the less appreciated and less understood roles in biopharma alliances—particularly codevelopment, cocommercial alliances—is that of the medical affairs team, specifically medical science liaisons (MSLs). These field-level folks implement a medical affairs plan and... Continue Reading

Postedby Michael Burke
Date posted09/25/2019


Undivided Attention: The BMS-Concerto Story
Undivided Attention: The BMS-Concerto Story

Nontraditional alliances took center stage (literally) yet again today as the opening session at the ASAP BioPharma Conference 2019 got under way in Boston. Titled “Building Value in Non-Traditional Pharma/Biotech Partnerships: BMS and Concerto Health AI,” the session was moderated by... Continue Reading

Date posted09/25/2019


When Worlds Converge: Digital Therapeutics Meets Biopharma Alliance Management
When Worlds Converge: Digital Therapeutics Meets Biopharma Alliance Management

Even a year or two ago, the idea of digital therapeutics didn’t stir up a great amount of interest among most participants at ASAP’s BioPharma Conference, according to Mike Leonetti, president and CEO of ASAP. That sort of ambivalence no longer applies, as was evident at the September... Continue Reading

Postedby Michael Burke
Date posted09/24/2019